4
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2024-04-01
Sage Accounts Production Advanced 2023 - FRS102_2023
382,481
329,583
xbrli:pure
xbrli:shares
iso4217:GBP
9430207
2024-04-01
2025-03-31
9430207
2025-03-31
9430207
2024-03-31
9430207
2023-04-01
2024-03-31
9430207
2024-03-31
9430207
2023-03-31
9430207
bus:RegisteredOffice
2024-04-01
2025-03-31
9430207
bus:Director1
2024-04-01
2025-03-31
9430207
bus:Director2
2024-04-01
2025-03-31
9430207
bus:CompanySecretary1
2024-04-01
2025-03-31
9430207
core:WithinOneYear
2025-03-31
9430207
core:WithinOneYear
2024-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2024-04-01
2025-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2023-04-01
2024-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2024-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2023-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2025-03-31
9430207
core:RetainedEarningsAccumulatedLosses
2024-03-31
9430207
core:ShareCapital
2025-03-31
9430207
core:ShareCapital
2024-03-31
9430207
core:CostValuation
core:Non-currentFinancialInstruments
2024-03-31
9430207
core:AdditionsToInvestments
core:Non-currentFinancialInstruments
2025-03-31
9430207
core:CostValuation
core:Non-currentFinancialInstruments
2025-03-31
9430207
core:Non-currentFinancialInstruments
2025-03-31
9430207
core:Non-currentFinancialInstruments
2024-03-31
9430207
bus:SmallEntities
2024-04-01
2025-03-31
9430207
bus:AuditExempt-NoAccountantsReport
2024-04-01
2025-03-31
9430207
bus:SmallCompaniesRegimeForAccounts
2024-04-01
2025-03-31
9430207
bus:PrivateLimitedCompanyLtd
2024-04-01
2025-03-31
9430207
bus:AbridgedAccounts
2024-04-01
2025-03-31
COMPANY REGISTRATION NUMBER:
9430207
|
Unaudited Abridged Financial Statements |
|
|
Abridged Financial Statements |
|
Year ended 31 March 2025
|
Abridged statement of income and retained earnings |
2 |
|
|
|
Abridged statement of financial position |
3 |
|
|
|
Notes to the abridged financial statements |
5 |
|
|
Year ended 31 March 2025
The directors present their report and the unaudited abridged financial statements of the company for the year ended
31 March 2025
.
Directors
The directors who served the company during the year were as follows:
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on
1 August 2025
and signed on behalf of the board by:
|
Dr S Bansal |
Dr S Bansal |
|
Director |
Company Secretary |
|
|
|
Registered office: |
|
90 Copse Hill |
|
Harlow |
|
Essex |
|
CM19 4PP |
|
|
Abridged Statement of Income and Retained Earnings |
|
Year ended 31 March 2025
|
2025 |
2024 |
|
Note |
£ |
£ |
|
Gross profit |
336,622 |
317,790 |
|
|
|
|
Administrative expenses |
26,242 |
29,838 |
|
--------- |
--------- |
|
Operating profit |
310,380 |
287,952 |
|
|
|
|
Income from other fixed asset investments |
182,621 |
154,674 |
|
Other interest receivable and similar income |
22,476 |
2,141 |
|
|
--------- |
--------- |
|
Profit before taxation |
5 |
515,477 |
444,767 |
|
|
|
|
|
Tax on profit |
132,996 |
115,184 |
|
--------- |
--------- |
|
Profit for the financial year and total comprehensive income |
382,481 |
329,583 |
|
--------- |
--------- |
|
|
|
|
Dividends paid and payable |
(
1,000) |
(
2,000) |
|
|
|
|
Retained earnings at the start of the year |
3,574,681 |
3,247,098 |
|
------------ |
------------ |
|
Retained earnings at the end of the year |
3,956,162 |
3,574,681 |
|
------------ |
------------ |
|
|
|
All the activities of the company are from continuing operations.
|
Abridged Statement of Financial Position |
|
31 March 2025
Fixed assets
|
Tangible assets |
6 |
|
16,507 |
33,014 |
|
Investments |
7 |
|
4,366,760 |
3,595,400 |
|
|
------------ |
------------ |
|
|
4,383,267 |
3,628,414 |
|
|
|
|
|
Current assets
|
Debtors |
7,872 |
|
– |
|
Cash at bank and in hand |
251,662 |
|
206,961 |
|
--------- |
|
--------- |
|
259,534 |
|
206,961 |
|
|
|
|
|
Creditors: amounts falling due within one year |
686,439 |
|
260,494 |
|
--------- |
|
--------- |
|
Net current liabilities |
|
426,905 |
53,533 |
|
|
------------ |
------------ |
|
Total assets less current liabilities |
|
3,956,362 |
3,574,881 |
|
|
------------ |
------------ |
|
Net assets |
|
3,956,362 |
3,574,881 |
|
|
------------ |
------------ |
|
|
|
|
Capital and reserves
|
Called up share capital |
|
200 |
200 |
|
Profit and loss account |
|
3,956,162 |
3,574,681 |
|
|
------------ |
------------ |
|
Shareholders funds |
|
3,956,362 |
3,574,881 |
|
|
------------ |
------------ |
|
|
|
|
These abridged financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements
.
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.
|
Abridged Statement of Financial Position (continued) |
|
31 March 2025
These abridged financial statements were approved by the
board of directors
and authorised for issue on
1 August 2025
, and are signed on behalf of the board by:
Company registration number:
9430207
|
Notes to the Abridged Financial Statements |
|
Year ended 31 March 2025
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 90 Copse Hill, Harlow, CM19 4PP, Essex.
2.
Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
4
(2024:
4
).
5.
Profit before taxation
Profit before taxation is stated after charging:
|
2025 |
2024 |
|
£ |
£ |
|
Depreciation of tangible assets |
16,507 |
16,508 |
|
-------- |
-------- |
|
|
|
6.
Tangible assets
|
£ |
|
Cost |
|
|
At 1 April 2024 and 31 March 2025 |
66,029 |
|
-------- |
|
Depreciation |
|
|
At 1 April 2024 |
33,015 |
|
Charge for the year |
16,507 |
|
-------- |
|
At 31 March 2025 |
49,522 |
|
-------- |
|
Carrying amount |
|
|
At 31 March 2025 |
16,507 |
|
-------- |
|
At 31 March 2024 |
33,014 |
|
-------- |
|
|
7.
Investments
|
£ |
|
Cost |
|
|
At 1 April 2024 |
3,595,400 |
|
Additions |
771,360 |
|
------------ |
|
At 31 March 2025 |
4,366,760 |
|
------------ |
|
Impairment |
|
|
At 1 April 2024 and 31 March 2025 |
– |
|
------------ |
|
Carrying amount |
|
|
At 31 March 2025 |
4,366,760 |
|
------------ |
|
At 31 March 2024 |
3,595,400 |
|
------------ |
|
|
8.
Related party transactions
There are no transactions with related parties that are required to be disclosed under Financial Reporting Standard for Smaller Entities.